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ABSTRACT
Laboratory rats are commonly used in life science research as a model for human biology and
disease, but the composition and development of their gut microbiota during life is poorly
understood. We determined the fecal microbiota composition of healthy Sprague Dawley
laboratory rats from 3 weeks to 2 y of age, kept under controlled environmental and dietary
conditions. Additionally, we determined fecal short-chain fatty acid profiles, and we compared the
rat fecal microbiota with that of mice and humans. Gut microbiota and to a lesser extent SCFAs
profiles separated rats into 3 different clusters according to age: before weaning, first year of life
(12- to 26-week-old animals) and second year of life (52- to 104-week-old). A core of 46 bacterial
species was present in all rats but its members’ relative abundance progressively decreased with
age. This was accompanied by an increase of microbiota a-diversity, likely due to the acquisition of
environmental microorganisms during the lifespan. Contrastingly, the functional profile of the
microbiota across animal species became more similar upon aging. Lastly, the microbiota of rats
and mice were most similar to each other but at the same time the microbiota profile of rats was
more similar to that of humans than was the microbiota profile of mice. These data offer an
explanation as to why germ-free rats are more efficient recipients and retainers of human
microbiota than mice. Furthermore, experimental design should take into account dynamic
changes in the microbiota of model animals considering that their changing gut microbiota







Higher animals are meta-organisms in which microbes
roughly equal host cells.1 The mammalian gastrointesti-
nal tract (GIT) is home to a large and complex micro-
bial community with distinct compositions in different
animal species related to their anatomic specificities and
habitual diet (frugivorous, herbivorous, folivorous, car-
nivorous, omnivorous).2 Gut microbes encode impor-
tant biologic functions that affect host gut homeostasis
(eg host nutrient metabolism, development and mainte-
nance of the gut mucosal barrier, immunomodulation,
protection against pathogens, xenobiotic and drugs
metabolism).3,4 Understanding of the composition of
the human gut microbiota and its potential influence
on health stems mainly from cohort studies. These stud-
ies were facilitated by recent advances in bioinformatics,
metabolomics and sequencing technologies,5,6 but also
informed by studying animal models.7 It is therefore
important to develop a better understanding of gut
microbiota in the laboratory animals routinely used in
pre-clinical models for human microbiota studies.
Rats and mice are among the most frequently used
laboratory animals in diverse fields of life sciences
including the microbiome, because of their gross physi-
ologic similarities to humans, as well as similarities
regarding their GIT anatomy at the organ, tissue and
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cell level.8 However, differences such as expanded colon
and cecum capacity and distribution of particular cell
types (e.g. Paneth cells absent in the cecum and proxi-
mal colon) are also evident.8,9 Utilization of mice instead
of rats as a laboratory model has several advantages
including small animal size, relatively low housing costs
and the availability of well-established transgenic mouse
strains as models for various human diseases.10 Refine-
ments of the model include Germ-Free (GF) animals
and their use as recipients for microbiota transplanta-
tion. This so-called “humanization” of the rodent GIT
with human gut microbiota11,12 has improved the appli-
cability of mice as a model for human gut-related stud-
ies. However some limitations have been identified; e.g.,
upon humanization, the mouse microbiota may develop
as a hybrid microbiota which is neither human- nor
mouse-like.13 In contrast, the rat (Rattus norvegicus) has
been reported to better sustain human-like fecal micro-
biota profiles.14-16 Among various rat lineages, the non-
consanguine Sprague-Dawley rat is widely used as
model of human biology in several life science arenas
(e.g., nutrition, pharmacology, toxicology) but little is
known about its gut microbiota especially its evolution
during the lifespan of the animals. Brooks and col-
leagues16 reported only 2 microbial phyla in the gut
microbiota of Wistar rats, with about 2 thirds of the 44
OTUs (96% sequence identity) detected being classified
as Firmicutes, and the remainder as Bacteroidetes.
Improved sequencing throughput has led to a deeper
understanding of these gut microbes in rats (e.g., refer-
ences13,15,17). However, data remains sparse, and to our
knowledge, the relationship between age and microbiota
composition has not yet been studied in rats, in contrast
to the human gut ecosystem.18,19
We therefore studied the fecal microbiota of a com-
mon laboratory rat lineage, the Norwegian Sprague
Dawley rat, in a cross-sectional study under controlled
environmental and dietary conditions. We report here
the fecal microbiota of healthy animals over their life-
span and we compare it to the microbiota profiles of
mice and humans.
Results
Rat gut microbiota composition changes
significantly with aging
We studied the fecal microbiota of rats kept under
controlled environmental conditions from birth as a
function of their chronological age. After weaning at
3 weeks of age, rats remained on a constant diet
(breeding rat diet) till week 12, when they were fed
with an aging rat diet onwards (see Methods section
and Table S6 for feed composition). The microbiota
was sampled at weeks 3, 12, 14, 26, 52, 78 and 104.
Fecal profiling revealed large microbiota composition
differences between rats grouped according to their
age (Fig. 1A and B), reflected in hierarchical clustering
based on the microbiota into 3 groups: Prior to wean-
ing (PW), after weaning Y1 (12-week-old to 26-week-
old animals) and Y2 (52-week-old to 104-week-old
animals). The relative abundance of several individual
bacterial taxa was differentially associated with the dif-
ferent age groups (Fig. 1C and Table 1, the propor-
tions by age at various taxonomic levels are provided
in Fig. S1 and Tables S1 and S2). These taxa were
derived principally from the phylum Firmicutes and
phylum Bacteroidetes at both extremities of life, while
Verrucomicrobia (Akkermansia) accounts for a sub-
stantial proportion of the Y1 microbiota composition
(Fig. 1C). The Firmicutes: Bacteroidetes ratio (F/B)
was similar for both the Y1 and Y2 clusters (respec-
tively 1.73 and 1.45) but was significantly lower in PW
rats (0.56, p < 0.001). The pre-weaning microbiota
composition was characterized by higher abundance
of taxa including Bacteroides, Lactobacillus, Blautia,
Clostridium XI and Klebsiella compared with Y1 and
Y2, likely influenced by suckling which stopped at
week 3. The microbiota of Y1-rats was discernible
from PW and Y2 mainly based on the high relative
abundance of Akkermansia spp., Clostridium XIVa
spp, Lachnospiraceae, Alistipes spp and Odoribacter
spp, among others. Bacteria differentially associated
with Y2 were classified as Barnesiella, Clostridiales,
Ruminococcaceae, Ruminococcus and Clostridium IV,
among others (Table 1; see also Tables S1 and S2).
Dynamics of the gut microbial ecosystem
The microbiota compositional differences were also
reflected in a progressive increase of the a-diversity
determined by the Shannon effective number of spe-
cies, ranging from 19.20 § 8.62 in PW to 38.53 §
14.70 for Y1 and 88.30 § 22.38 for Y2 (Fig. 2A). Not-
withstanding the dramatic variations in microbiota
composition over the rat life-span, many OTUs were
present in young as well as old animals (Fig. 2B).
Comparing the core microbiota at different life stages
(see Methods for details) highlights the dynamics of
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the gut microbial ecosystem. The youngest rats dis-
played the lowest species richness (180 OTUs per ani-
mal) across all analyzed life stages (Fig. 2C). Roughly
one quarter of these OTUs (46 OTUs) were fre-
quently present in most rats regardless of age, repre-
senting an age-independent core microbiota (labeled
“Core” in Fig. 2B and C). Interestingly, this “Core”
made up 83.7% of all reads in PW rats (Fig. 2C).
Another quarter of the total OTUs (47 OTUs), com-
prising 9.7% of all reads, was only frequently present
in PW (Labeled “Core PW” in Fig. 2B and C), indi-
cating an adaptation to the gut ecosystem at this par-
ticular age/diet. The remainder of OTUs comprised
the core microbiota of older animals as well as a set
of rare taxa (combined abundance 1.3%) not com-
monly present in most rats regardless of age (“Vari-
able”), possibly representing transient or subject-
specific microbes. The richness increased to 321
OTUs and to 492 OTUs respectively in Y1 and Y2
animals. It was accompanied by a decrease of the
abundance of the “Core” falling from 83.7% of all
reads to 36.3% and 9.6% (red line in Fig. 2C). In Y1
animals, the “Core” was complemented by 52 OTUs
only frequently present and abundant at this age
(“Core Y1;” 14.7% of all reads) as well as 68 OTUs
which were also frequently present and abundant in
the oldest animals (“Core Y1Y2;" 39.9% of all reads).
In Y2 animals a set of 172 OTUs comprised 65.8% of
Figure 1. The composition of the fecal microbiota of rats is strongly associated with animal age. (A) Principal coordinates analysis (PCoA)
of the unweighted UniFrac distance matrix and (B) hierarchical clustering separates rats into 3 groups according to age: 3 week old rats
(Prior to weaning), 12 to 26 week old rats (Year 1) and 52 to 104 week old rats (Year 2). (C) Relative abundance of bacterial genera across
the first 2-year lifespan of rats. Genera with an average relative abundance below 1% are grouped under “rare.genera” in the figure
labeling.
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all reads and was only frequently present and abun-
dant in this age group (“Core Y2”). On average 41.2%
of the 492 OTUs (combined abundance 6.7%) of 2-
year-old animals comprised OTUs present in only a
subset of animals (“Variable”). It has previously been
reported that methanogens become proportionally
more abundant in the gut microbiota of rats with
aging.20 Surprisingly, methanogenic archaea were
either not detected or their abundance was below
0.05%. The recovered sequences belonged to the
Methanobacteriales taxa Methanobrevibacter spp and
Methanosphaera spp, as well as the recently discov-
ered Methanomassiliicoccales, therefore showing a
similar diversity to the one encountered in humans.21
The low prevalence and abundance was further con-
firmed by qPCR analyses (data not shown).
Fecal levels of short chain fatty acids correlate with
age and gut microbiota composition
Fecal levels of short chain fatty acids (SCFAs) are
associated with the composition of the human gut
Figure 2. The phylogenetic diversity of the rat gut microbiota increases with age. (A) Fecal bacterial a-diversity across the lifespan of
rats (Shannon effective number of species). (B) Heat-map of fecal bacterial OTU abundance shows the dynamics of the microbiota across
the lifespan of rats. An age independent “Core” microbiota (see Materials and Methods) is supplemented with bacteria specific to the
developmental stage of the rat (i.e., “Core PW,” “Core Y1” and “Core Y2”) and with bacteria incorporated into most animal’s fecal micro-
biota as permanent members (i.e., “Core Y1Y2”). Bar graphs of Species richness (C) and relative OTU abundance (D) across the lifespan
of rats and contributions of the different cores to these values. The increase in diversity is largely due to the “Variable” group of OTUs,
i.e., OTUs which are only found in a subset of animals. Note the concomitant decrease in relative abundance (red line in panel C) but
not presence of “Core” OTUs. The hinges of the boxes in the box-and-whisker plots represent the 25th to 75th percentile with the 50th
percentile (median) drawn as the line inside the box. Whiskers extend to 1.5 times the interquartile range. All: Color coded as per
legends to the right.
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microbiota and of the diet.22 We thus measured fecal
acetate, butyrate, propionate, caproate, heptanoate,
isocaproate, isovalerate, isobutyrate and valerate lev-
els and examined correlations with bacterial abun-
dance. Although there is a degree of overlap, the
overall profile of fecal SCFAs was significantly dif-
ferent between younger and older rats especially
PW compared with Y2 (Fig. 3A). Fecal total SCFAs
significantly increased with age (p < 0.001 for rats of
year 2 against both PW and Y1 rats), mainly corre-
sponding to an increase in levels of acetate, butyrate
and propionate (Fig. 3B; Fig. S2). Other less abun-
dant SCFAs did not change in concentration and
because they were present in low levels, this had no
net effect on total SCFA levels (Fig. S2). Furthermore,
both several individual taxa (Table S3) and the sum
of the abundance of the taxa that define bacterial
clusters of Figure 1B significantly correlated with
fecal levels of SCFAs (Fig. 3C).
Age is reflected in the predicted functional profile of
the fecal microbiota
Prediction of the biochemical function of the
microbiota was performed using PICRUSt software,
which infers microbiota function based on genomes
of reference organisms considering the relative
abundance of genes involved in 256 KEGG path-
ways.23 The predicted functional profile of the
microbiota was significantly different between rats
of different age (Table S4). Interestingly, the collec-
tive distances between the PW samples and
between Y1 samples on the PCoA (i.e. the areas
defined by these groups) were considerably greater
Figure 3. Fecal SCFA-levels in rats are associated with age and microbiota composition. (A) Principle coordinates analysis of the Spear-
man-rank distance and (B) boxplots of fecal SCFA levels reveal different SCFA profiles across the lifespan of the animals. Age groups and
colors as in Figure 1. (C) The levels of several SCFAs were correlated with total abundance of bacterial clusters (Fig. 1B). The title of each
panel indicates which SCFA was compared with which bacterial cluster and from which age group the samples were drawn. Blue lines
indicate the linear regression model and shaded areas indicate the corresponding upper and lower confidence intervals. r D Spear-
man’s rho. p D adjusted p-value (Benjamini-Hochberg). Only significant correlations shown. The hinges of the boxes in the box-and-
whisker plots represent the 25th to 75th percentile with the 50th percentile (median) drawn as the line inside the box. Whiskers extend
to 1.5 times the interquartile range.
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than Y2, indicating the acquisition of similar func-
tional profiles over time (Fig. S3).
The experimentally determined fecal SCFA levels
were corroborated by commensurate abundance of
genes associated with propanoate metabolism, buta-
noate metabolism and fatty acid biosynthesis in the
aging rat (Table S4). Moreover, the abundance of
bacterial clusters 1 and 3 was significantly nega-
tively and positively associated respectively with the
predicted gene count for these SCFA pathways
(Table S5). Also, predicted gene counts involved in
methane metabolism were significantly different
between PW and Y2 (P < 0.01) and between Y1
and Y2 (P < 0.001), with differences being non-
significant between PW and Y1 (P > 0.05)
(Table S4).
Interestingly, the predicted coding capacity of
pathways for biogenesis of bacterial motility pro-
teins, flagellar assembly and bacterial chemotaxis
all gradually increased in relative abundance over
time/age, indicating a general increase of microbial
motility in the aging rat. Furthermore, genes
encoding lipopolysaccharide biosynthesis became
less abundant with aging of the rats, suggesting a
net shift from gram-negative bacteria to gram-posi-
tive bacteria.
The abundance profiles of human core microbiota
OTUs are more similar in rats than in mice
As rats are commonly used as a model of human biol-
ogy, we were interested in comparing their fecal
microbiota composition with that of humans and
mice. We used data from 38 healthy elderly individu-
als (median age 68, 25th percentile 66 years, 75th per-
centile 70 years)24 and from a mouse microbiota study
currently performed at the APC Microbiome Institute
in Cork (14-week old mice). The sequencing library
preparation method was identical for all investigated
samples. However, there were differences in DNA
extraction methodology and sequencing chemistry
(Illumina’s 2 £ 250bp paired-end sequencing for
human samples versus 2 £ 300bp paired-end
sequencing for rodent samples). The microbiota of the
Figure 4. The fecal microbiota of 1 y old rats is more related to that of humans than it is to the microbiota of mice. (A) Unweighted Uni-
Frac principal coordinate analysis. Fecal microbiota of rodents is more closely related to each other than to human fecal microbiota.
Inset: Venn diagram of OTUs present inin faeces of humans, rats (only Y1) and micemice. (B) Box-plots of the relative abundance of
human core bacterial OTUs (OTUs present in at least 80% of human individuals). More reads of these OTUs were found in the microbiota
of up-to 1 y old animals (both PW and Y1) than in 14 week old C57Bl/6 mice. Except for comparison between “Mouse” and “Rat (Y2),” all
p-values were below 0.05 (pairwise Wilcoxon test, adjusted after Benjamini-Hochberg). (C) Boxplots of the pairwise distance to human
samples (weighted UniFrac). The distance was smallest for rats aged 12–26 weeks. All p-values below 0.05 (pairwise Wilcoxon test,
adjusted after Benjamini-Hochberg). Age groups and colors for rats as in Figure 1. The hinges of the boxes in the box-and-whisker plots
represent the 25th to 75th percentile with the 50th percentile (median) drawn as the line inside the box. Whiskers extend to 1.5 times
the interquartile range.
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human samples was mainly comprised of Firmicutes,
Bacteroidetes, Proteobacteria, Actinobacteria and Ver-
rucomicrobia (Fig. S4), as also has been reported
previously.25
Collectively, the gut microbiota of mice and rats
was more similar to each other than to the gut micro-
biota of humans (Fig. 4A). Nonetheless, the overall
abundance of the human core microbiota taxa (i.e.,
62 OTUs from 23 bacterial genera present in at least
80% of human individuals) was higher in 1-year-old
rats than in mice (Fig. 4B). This was also reflected in
the average UniFrac distances between all pairwise
human microbiota sample comparisons, vs. pairwise
between human samples and animal samples
(Fig. 4C), despite humans and rats share less OTUs
than humans and mice (49 specific common OTUs
vs 74, Venn-diagram inset Fig. 4A). In fact, some
important members of the human gut microbiota,
including Clostridium cluster XI, Akkermansia and
some Lachnospiraceae were found at similar relative
abundance in the faeces of rats, but not of mice
(Fig. S5). However, it has to be noted that many indi-
vidual human core-OTUs were either completely
absent in rats (e.g., OTUs classified as Bifidobacte-
rium, Collinsella, Blautia, Butyricicoccus, Gemmiger,
Lachnospira and Lachnospiraceae, Oscillibacter, Rumi-
nococcus) or displayed very low abundances in rats
(e.g., OTUs classified as Anaerostipes, Bacteroides,
Blautia, Coprococcus, Dorea, Faecalibacterium,
Hespellia, Lachnospiraceae, Oscillibacter, Roseburia,
Ruminococcus and Sporobacter).
Discussion
Rodents are among the most popular laboratory ani-
mals used in the life sciences, and mouse models are
frequently used to investigate the impact of the micro-
biota on health and disease. The current study con-
firms that pairs of rodent species have a more similar
gut microbiota than either does with human micro-
biota.2 Hampering the extrapolation of results from
animal models to humans is the difference in micro-
biota composition of humans and mice, largely cir-
cumvented by humanization of gnotobiotic mice.
However, humanized GF mice may still display a dif-
ferent microbiota to the human donor and health
modulating bacteria often fail to colonize the mouse
gut.26 These transplantation difficulties seem less
problematic in rats in which most high-abundance
human gut microbes were engrafted from donor feces
to GF rat recipients, in contrast to GF mice.13 Results
obtained here support the hypothesis of a closer simi-
larity of human and rats to their gut microbial compo-
sition than that between humans and mice, which
possibly accounts for the better engraftment of trans-
planted human microbiota into GF rats. This is
illustrated by the presence of some genera (eg Anaero-
truncus, Escherichia-Shigella, Oscillibacter, Rumino-
coccus) which were efficiently retained in rats after
inoculation from a human donor but which were not
retained by GF or AB-treated C57BL/6 mice.13 A
recent comparison of the gut microbiota of mice and
humans revealed 80 shared genera.27 This finding was
Table 1. Relative abundance of the 3 most abundant OTUs of each core.
OTU ID Mean PW (%) Mean Year 1 (%) Mean Year 2 (%) Core Genus
OTU0037 31.338 0.514 0.104 Core Bacteroides
OTU0047 7.710 7.120 3.464 Core Prevotella
OTU4360 2.134 14.005 0.069 Core Akkermansia
OTU0073 0.908 0.003 0.003 Core PW Klebsiella
OTU1371 0.691 0.011 0 Core PW Bacteroides
OTU1406 0.658 0.017 0.003 Core PW Barnesiella
OTU0067 0.005 5.738 0.031 Core Y1 Alistipes
OTU0132 0.009 1.677 0.071 Core Y1 Clostridium_XlVa
OTU5156 0.002 1.362 0.095 Core Y1 unclassified.Lachnospiraceae
OTU0075 0.002 0.001 12.873 Core Y2 Barnesiella
OTU0101 0.346 0.305 5.030 Core Y2 unclassified.Ruminococcaceae
OTU0218 0 0 3.222 Core Y2 Barnesiella
OTU0005 2.056 13.769 0.062 Core Y1Y2 Akkermansia
OTU0093 0.001 4.301 0.730 Core Y1Y2 Clostridium_XlVa
OTU0098 0.011 4.319 0.214 Core Y1Y2 unclassified.Lachnospiraceae
OTU0295 0.323 0.119 0.443 Core PWY2 Turicibacter
OTU0164 0.671 0.010 0.018 Core PWY2 Flavonifractor
OTU0006 0.115 0.018 0.469 Core PWY2 Roseburia
OTU0180 0.032 1.667 0.030 Variable Clostridium_XlVa
OTU0316 0 0 0.468 Variable Ruminococcus
OTU0593 0.143 0.245 0 Variable unclassified.Lachnospiraceae
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confirmed (79 genera) by a meta-analysis8 while some
genera were found specifically in humans and not in
mice.27 Our study also indicates that most of these
genera are not found in rats (Asteroleplasma, Mitsuo-
kella, Megasphaera, Paraprevotella, Succinivibrio), but
some were detected here like Sutterella and Phasco-
larctobacterium (mainly in Y2 rats) or Faecalibacte-
rium (also mentioned in mice by8), and to a lesser
extend Dialister (detected only once in an Y2 rat).
Also, many individual human core-OTUs were either
completely absent or displayed very low abundances
in rats, but some genera were present either in some
Y2 animals (Bifidobacterium and Gemmiger) or in all
age-groups PW/Y1/Y2 (Blautia, Butyricicoccus, Oscil-
libacter, Ruminococcus). In addition, some important
members of the human gut microbiota (Clostridium
XI, Akkermansia and some Lachnospiraceae) dis-
played similar relative abundance in the feces of rats,
but not of mice. Therefore, the in-house bred rats in
this study naturally present a greater gut microbiota
similarity to humans than to mice, varying during
their lifespan.
With respect to the age-microbiota interaction, a
limitation of the current study design was its cross-
sectional nature, and we acknowledge that a longitudi-
nal design, serially sampling tagged individual ani-
mals, would have yielded superior results.
Nevertheless, our data provides evidence that colony
(including the seed microbiota) was not a main con-
tributor to the observed age-associated differences in
microbiota composition. The source of the animals
used in this study is a leading supplier of laboratory
rodents in Europe and all breeding and housing was
performed under optimized controlled conditions (fil-
tered air, sterile diet, access restricted to dedicated
technicians). Furthermore, animals were all born in
the same environment (isolation chambers). So
despite the fact that the animals were born on differ-
ent days within a 2-year timeframe and were thus
likely exposed to different maternal seed microbiotas,
carefully controlling for external conditions including
for the microbial environment appears to have accom-
plished introducing minimal bias. Supporting this
contention, if, despite the careful setup, colony indi-
vidualism had exerted a major effect on the micro-
biota, we would have been able to detect this effect
during our analysis. However, when we analyzed data
from 2 different colonies of rats during year 1 after
weaning (12-week-, 14-week- and 26-week-old rats;
samples from 12-week-old and 14-week-old rats came
from the same colony) and from 3 different colonies
during year 2 (52-,78- and 104-week-old rats), the
samples from the different colonies clustered mainly
by age (Fig. 1A) and not by colony. We thus conclude
that we have detected a true age-effect and that possi-
ble effects of colony and/or seeding of the microbiota
are secondary.
In-house breeding of Sprague Dawley rats was con-
ducted under controlled dietary and environmental
conditions, with no medication / antibiotics adminis-
tered. The fecal microbiota profiles were determined
from healthy rats ranging from their weaning to more
than 700 d of life. This revealed changes across age
with 3 main stages beginning at weaning with a low-
diversity microbiota being progressively enriched, pre-
sumably by constant exposure to environmental
microorganisms. This led to an increased diversity
and a concomitant gradual diminution of the core
microbiota abundance, decreasing from more than
80% of all reads in PW to less than 10% in Y2
(Fig. 2B). This finding points out the importance of an
initial seed microbiota that will be kept during life and
which may affect the acquisition of other microbes.
Diet appears to be an important factor that shapes the
microbiota as observed during the transition from PW
to Y1. However, the diet change at week 12 had little
effect as shown by a similar profile at weeks 12, 14 and
26. Furthermore, the fact that the Y2 microbiota com-
position separates from Y1 even though the diet was
unchanged indicates that other factors have to be con-
sidered. This is particularly evident between 26 and
52 weeks after birth: The collective capacity of the
microbiota to perform amino acid metabolism
severely decreased between Y1 and Y2, as did the
metabolism of cofactors and vitamins (Table S4). This
was however not the case for biotin / Vit B7 in con-
trast to what has been reported to occur in a model of
frailty in mice.28 This possibly reflects the absence of
detectable frailty readouts in the aged rats in this
study. Anyway, factors other than diet that shape the
microbiota in older rats may include general physio-
logic modifications induced by aging, with Y2 corre-
sponding to a new biologic stage in the life of rats.
While the gut is likely exposed continuously to new
microbes, some thrive only for a limited length of
time, possibly fulfilling important temporary func-
tional roles for gut homeostasis. However, others may
become incorporated as permanent members of the
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microbiota when provided permissive ecological con-
ditions, possibly at peculiar stage of rats’ life indepen-
dently of the diet. Our data also provide clues that the
selection of particular microorganisms to which rats
are exposed is driven by an adaptation of the gut
microbiota to a more efficient energy-harvesting con-
figuration to act upon accessible nutrients, illustrated
by the acquisition of similar functional profiles over
time. These microbial changes affect SCFA production
which in turn likely affects the physiology of the rat.
Importantly, among the functional microbial changes,
the increase in motility genes observed in aging rats
merits further attention in the context of aging related
inflammation and metabolic disorders, recognizing
that flagellin is a canonical TLR5 ligand,29 and that
TLR5 has a surveillance role which when disturbed
leads to obesity.30
In conclusion, the gut microbiota of healthy labora-
tory rats changes throughout the lifespan. However,
they maintain a core microbiota and display an
increased diversity that corresponds to the acquisition
of more similar functional profiles across animals.
Despite the absence of some genera found in humans,
or the presence of specific ones shared with mice, fecal
microbiota in cluster Y1 rats was more related to that
of humans than mice. This likely accounts for the
higher similarity to the initial human fecal inoculum
achieved in gnotobiotic rats compared with mice.13,14
Overall, considering the metabolic behavior of the gut
microbiota, the dynamics of the gut microbiota in rats
should be taken into account when using rats for pre-
clinical models e.g., for nutritional or toxicological
studies.
Materials and methods
Study design and breeding conditions of animals
Animals (Rattus norvegicus Sprague-Dawley) were
bred in Janvier Labs (Le Genest Saint Isle, France)
with a certified management system for the breeding,
purchase and delivery of rodents devoted to research
and biomedical control. Only dedicated trained staff
was handling animals in the controlled conditions of
the laboratory equipped with appropriate ventilation
and technical equipment. Animals were bred from
birth to 12 weeks in a specific production unit and
then transferred by aseptic methods to another unit.
Only animals with no signs of disease at the moment
of sampling (fecal pellets) were used. The health status
of each animal colony was assessed by an independent
laboratory using FELASA-based recommendations.
Rats were randomly chosen from different cages for
sampling of fecal pellets to avoid coprophagy-induced
cross-contamination of samples.31 Rats had ad lib
access to water (6–8ppm chlorinated, pH D 5) and
food. Autoclaved food was composed of a complete
feed for rats with 18% crude proteins (ssniff S8189-
S105) from 3 weeks to 12, then replaced by a complete
feed with 15% crude proteins (ssniff S8189-S085)
(ssniff Spezialdi€aten GmbH, Germany). Detailed com-
position of these feeds are given in Table S6. Rats were
sampled at weeks 3 after birth (before weaning or
PW), at weeks 12, 14 and 26 (referred as year 1 or Y1),
and at weeks 52, 78 and 104 (Year 2 or Y2). The study
was cross-sectional as rats of different ages were all
sampled at the same date (C/¡ 2 days) with the
exception of rats aged 12 and 14 weeks, which were
randomly chosen from the same colony and which
were sampled at the 2 time-points. The total number
of samples/animals studied per time-point was as fol-
lows: Week 3: 8; Week 12: 8; Week 14: 8; Week 26: 7;
Week 52: 8; Week 78: 7; Week 104: 8. To compare the
microbiota of rats with the microbiota of laboratory
mice and elderly humans we included sequencing data
from 38 elderly healthy individuals24 and from 10
mice (14-week-old) of an ongoing study in the APC
Microbiome Institute in the analysis. The sequencing
data for these samples was available and all sequences
were processed together as described in “Analysis of
16S amplicon sequencing data.”
Extraction of nucleic acids, 16S rRNA amplicon
sequencing and qPCR analyses
DNA was extracted from 250 mg of frozen rat stool
using the protocol of Yu and Morrison coupled with
Qiagen DNA Stool Mini Kit (Qiagen, West Sussex,
UK).32 DNA from 180–220 mg of mouse stool was
extracted using Qiagen’s QIAamp Fast DNA Stool
mini kit. DNA quantifications were performed using
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE). Libraries for 16S
rRNA amplicon sequencing of the V3 and V4 regions
were prepared following the guidelines provided by
Illumina (San Diego, USA; Part #15044223, Rev. B).
In brief, 50 ng of extracted fecal DNA were subjected
to a PCR with 25 cycles, followed by purification using
Agencourt XP beads (Beckman Coulter, Takeley, UK).
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Then dual multiplexing barcodes were annealed to
each amplicon and the reactions were purified again.
Finally, amplicons were pooled to equimolar concen-
trations and sequenced on a MiSeq using 2300 bp
chemistry (Illumina, San Diego, USA). Sequence of
the primers used were TCGTCGGCAGCGTCAG
ATGTGTATAAGAGACAGCCTACGGGNGGCW
GCAG (V3, forward) and GTCTCGTGGGCTCGGA
GATGTGTATAAGAGACAGGACTACHVGGGTA
TCTAATCC (V4, reverse). Detection of methanogens
was performed by quantitative PCR using specific pri-
mers forMethanobrevibacter smithii, Methanosphaera
stadtmanae and Methanomassiliicoccales. Primer
sequences and annealing temperatures have been
described previously for M. smithii and M. stadtma-
nae.33 Primers for Methanomassiliicoccales were
GATTCTGAGACACGAATCCAGG and CGTCTTA
CCCAGCCCTTATTC (Ca. Methanomethylophilus
alvus digestive cluster), used at an annealing tempera-
ture of 58C. Reactions were performed using reac-
tants (Brilliant III Ultra-Fast SYBR Green QPCR,
Agilent, Palo-Alto, CA, USA) and manufacturer
instructions on the Mx-3005P qPCR apparatus
(Agilent, Palo-Alto, CA, USA).
Analysis of 16S amplicon sequencing data
Analysis of 16S rRNA amplicon data was performed as
described previously.24 Briefly, barcodes were reattached
to the libraries, which were obtained as demultiplexed
libraries per sample, adaptors were removed and paired-
end sequencing reads were merged using FLASH.34
Merged sequences were then processed in QIIME35 and
usearch36 to obtain an OTU table. Representative
sequences were classified using mothur37 against the 16S
rRNA reference of RDP, version 14. Additionally, an
OTU-table was obtained using QIIMEs pick_closed_re-
ference_otus.py and the green genes database version
13_5 for input into PICRUSt.38,23
Short chain fatty acids analysis
Fecal samples were weighed, diluted in 2 mL of sterile
water and then centrifuged (8,000 £ g, 10 min). 85 ml
of 2-ethylbutyric acid (49 mM) and 20 ml of phospho-
tungstic acid (500 g.L¡1) were added to the superna-
tant and samples were then incubated at 4C
overnight. Acetate, propionate, butyrate, isobutyrate,
valerate, isovalerate, caproate, isocaproate and hepta-
noate were assayed using gas chromatography using
2-ethyl-butyrate as internal standard (HP 6890 series,
column HP-INNOVAX 30 m £ 250 mm £ 0.25 mm,
split ratio D 25:1, Agilent Technologies, Palo Alto,
CA, USA).39 The concentration of SCFAs was normal-
ized against the initial stool weight.
Statistical analysis
Statistical analysis was performed in R40 using appro-
priate methods including paired or non-paired t-test
or Wilcoxon-tests and permutational multivariate
analysis of variance using distance matrices (pMA-
NOVA). Distance matrices were calculated using
unweighted UniFrac, weighted UniFrac41 and Spear-
man-rank distance. Correction for multiple testing
was performed using the method of Benjamini and
Hochberg.42 Rat core-microbiota across different
developmental stages was determined as follows. The
“core” microbiota comprises all OTUs which were
present in at least 80% of rats of each age group, i.e.,
present in 80% or more of prior-to-weaning rats,
year-1 rats and year-2 rats. Similarly, the “core PW”
comprises OTUs which were present in at least 80% of
prior-to-weaning rats. Core Y1: OTUs present in at
least 80% of 12-week-old to 26-week-old rats. Core
Y2: OTUs present in at least 80% of 52-week-old to
104-week-old rats. Core PWY2 and Core Y1Y2 com-
binations of above (no OTUs in group Core PWY1).
Variable: OTUs not in any of above categories. In the
case where OTUs qualified for 2 groups the group
containing more age-groups took precedence e.g.,
OTUs in Core Y1Y2 would also qualify for either
Core Y1 or Core Y2, but membership of Core Y1Y2
took precedence.
Availability of materials and data
Rat microbiota sequencing data has been submitted to the
European Nucleotide Archive (ENA) and is publicly available
under the study number PRJEB21217 (http://www.ebi.ac.uk/
ena/data/view/PRJEB21217).
Abbreviations
F/B Firmicutes vs Bacteroidetes ratio
GF germ-free
GIT Gastro-intestinal tract
KEGG Kyoto encyclopedia of genes and genomes
LPS lipopolysaccharides
NGS Next-generation sequencing
OTU operational taxonomic units
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PCoA principal coordinates analysis
pMANOVA permutational multivariate analysis of
variance
PW before weaning
QIIME quantitative insights into microbial
ecology
SCFAs short-chain fatty acids
TLR5 Toll-like receptor 5
Y1 year one
Y2 year two
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